The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
ID: ALA1527011
Max Phase: Preclinical
Molecular Formula: C15H12N2O
Molecular Weight: 236.27
Molecule Type: Small molecule
Associated Items:
Representations Canonical SMILES: Oc1nc(-c2ccccc2)c(-c2ccccc2)[nH]1
Standard InChI: InChI=1S/C15H12N2O/c18-15-16-13(11-7-3-1-4-8-11)14(17-15)12-9-5-2-6-10-12/h1-10H,(H2,16,17,18)
Standard InChI Key: JAWYWGRTWUVTEN-UHFFFAOYSA-N
Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Properties Molecular Weight: 236.27Molecular Weight (Monoisotopic): 236.0950AlogP: 3.45#Rotatable Bonds: 2Polar Surface Area: 48.91Molecular Species: NEUTRALHBA: 2HBD: 2#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 2#RO5 Violations (Lipinski): 0CX Acidic pKa: 9.46CX Basic pKa: 3.04CX LogP: 3.84CX LogD: 3.83Aromatic Rings: 3Heavy Atoms: 18QED Weighted: 0.72Np Likeness Score: -0.54
References 1. PubChem BioAssay data set, 2. Chen H, Knerr L, Åkerud T, Hallberg K, Öster L, Rohman M, Österlund K, Beisel HG, Olsson T, Brengdhal J, Sandmark J, Bodin C.. (2014) Discovery of a novel pyrazole series of group X secreted phospholipase A2 inhibitor (sPLA2X) via fragment based virtual screening., 24 (22): [PMID:25316315 ] [10.1016/j.bmcl.2014.09.058 ]